Ratings by Jefferies (Kelechi Chikere)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/23/2021 | Icosavax Inc. | ICVX | New Coverage | Buy (N/A) |
34.60 (15.31) |
-55.75% | Details | |
| 6/30/2021 | Altimmune | ALT | Maintain | Buy (Buy) |
|
Details | ||
| 6/24/2021 | Inovio Pharmaceuticals | INO | New Coverage | Hold (N/A) |
8.69 (10.09) |
16.11% | Details | |
| 6/24/2021 | Vaxart Inc. | VXRT | New Coverage | Buy (N/A) |
7.85 (0.83) |
-89.43% | Details | |
| 6/24/2021 | Vaxcyte | PCVX | New Coverage | Buy (N/A) |
21.48 (61.25) |
185.15% | Details | |
| 6/16/2021 | Altimmune | ALT | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2021 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 4/1/2021 | Yumanity Therapeutics Inc. | YMTX | New Coverage | Buy (N/A) |
17.28 (1.89) |
-89.06% | Details | |
| 3/26/2021 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2021 | VBI Vaccines | VBIV | New Coverage | Buy (N/A) |
3.46 (0.64) |
-81.5% | Details | |
| 2/25/2021 | Arbutus Biopharma | ABUS | New Coverage | Hold (N/A) |
3.83 (2.71) |
-29.24% | Details | |
| 1/29/2021 | Novavax | NVAX | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2020 | Altimmune | ALT | New Coverage | Buy (N/A) |
12.27 (6.79) |
-44.66% | Details | |
| 12/14/2020 | Novavax | NVAX | New Coverage | Buy (N/A) |
115.09 (3.91) |
-96.6% | Details |
